The Alzheimer's Drug Aduhelm, Approved Last Year by the FDA in a Controversial Decision, ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'The Alzheimer’s drug Aduhelm, approved last year by the FDA in a controversial decision, was heralded as a game changer for patients. Instead, it has researchers wondering if they've hit a multibillion-dollar dead end ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)